Identify
common technology gaps and unmet needs for the pharmaceutical industry
Partner
with third parties on the development of new technology
Explore
opportunities and strategies to meet new technology goals
Accelerate
the availability and commercialization of new technology
Advocate
for the pharmaceutical industry
Collaborate
via a structure optimized for shared resourcing and multi-party projects
Third Parties can seek to collaborate with ETC through either responding to one of our RFI/RFPs or the Third Party reaches out with their own project proposal for consideration by ETC.
ETC® Requests for Information/Proposals (RFI/RFP)
ETC regularly publishes RFI/RFPs seeking responses from the scientific community on specific collaboration opportunities.
Third Party
Proposes
Project to ETC
The scientific community is invited to submit a project idea to ETC for consideration as an ETC® Project
$7.4M+
Projects
$7.4M+
Projects
500+
Participants
500+
Participants
40+
40+
30
Collaborators
30
Collaborators
33
RFI/RFPs
33
RFI/RFPs
17
17
16
Companies
16
Companies
8
Groups
8
Groups
Matthew Bahr (GSK)
Nandu Nere (AbbVie)
Thank you for your interest in Enabling Technologies Consortium. Please complete the form below to subscribe to our mailing list for ETC news and notifications of new RFIs and RFPs, or to request information how your company can become a member of ETC.
